A Comparative Analysis of Total Thyroidectomy and Lobectomy as Surgical Approaches in Patients Undergoing Thyroid Surgery
DOI:
https://doi.org/10.70765/agg5h426Keywords:
lobectomy, total thyroidectomy, grave disease, general surgery.Abstract
Background: Many surgical procedures are required for thyroid diseases, with total thyroidectomy and lobectomy emerging as the two main techniques. The purpose of this study was to assess the relationship between clinical and demographic factors and the surgical management option selected for patients having thyroid surgery.
Methodology: Patients who had thyroid surgery were categorized into groups for complete thyroidectomy and lobectomy based on a retrospective analysis. Age, gender, BMI, place of residence, length of stay, hospital stay, and comorbidities such ischemic heart disease and diabetes mellitus were among the factors looked at. Chi-square tests were used to examine the relationships between these variables and the type of operation, and p-values were computed.
Result: Age, BMI, length of hospital stay, and diabetes mellitus did not significantly differ between the groups receiving total thyroidectomy and lobectomy, according to the research. Nonetheless, there was a tendency towards significance in terms of gender, with more men having complete thyroidectomies. Living in a rural area was significantly correlated with having a lobectomy, and being in the 1-3 month range was significantly correlated with having a total thyroidectomy. There was a trend towards significance in ischemic heart disease, indicating a possible correlation with the kind of surgery.
Conclusion: The parameters impacting the decision between a lobectomy and a complete thyroidectomy are clarified by this study. Gender, residence, duration, and ischemic heart disease showed significant relationships, while age, BMI, hospital stay, and diabetes mellitus did not significantly influence the decision. Additional investigation into these patterns may lead to more individualized surgical approaches for thyroid conditions, improving clinical judgment in thyroid surgery and improving patient outcomes.
Downloads
References
1: Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-132. DOI: https://doi.org/10.3322/caac.21338
2: Tuttle RM. Controversial issues in thyroid cancer management. J Nucl Med. 2018;59(8):1187-1194. DOI: https://doi.org/10.2967/jnumed.117.192559
3: Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. DOI: https://doi.org/10.1089/thy.2015.0020
4: Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783-2795. DOI: https://doi.org/10.1016/S0140-6736(16)30172-6
5: Pasqual E, Sosa JA, Chen Y, Schonfeld SJ, Berrington de González A, Kitahara CM. Trends in the management of localized papillary thyroid carcinoma in the US (2000-2018). Thyroid. 2022;32(4):397-410. DOI: https://doi.org/10.1089/thy.2021.0557
6: Momesso DP, Tuttle RM. Update on differentiated thyroid cancer staging. Endocrinol Metab Clin North Am. 2014;43(2):401-421. DOI: https://doi.org/10.1016/j.ecl.2014.02.010
7: Lamartina L, Durante C, Filetti S, Cooper DS. Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature. J Clin Endocrinol Metab. 2015;100(5):1748-1761. DOI: https://doi.org/10.1210/jc.2014-3882
8: Xu S, Huang H, Wang X, Liu S, Xu Z, Liu J. Long-term outcomes of lobectomy for papillary thyroid carcinoma with high-risk features. Br J Surg. 2021;108(4):395-402. DOI: https://doi.org/10.1093/bjs/znaa129
9: J.R. Sorensen et al. The impact of goiter and thyroid surgery on goiter related esophageal dysfunction A Systematic Review. Front Endocrinol (Lausanne) (2018) DOI: https://doi.org/10.3389/fendo.2018.00679
10: N. Alsaleh et al. Effectiveness of hemi-thyroidectomy in relieving compressive symptoms in cases with large multi nodular goiter Ann Med Surg (Lond) (2021) DOI: https://doi.org/10.1016/j.amsu.2021.01.088
11: Ruel E, Thomas S, Dinan M, Perkins JM, Roman SA, Sosa JA. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab. 2015;100(4):1529-1536. DOI: https://doi.org/10.1210/jc.2014-4332
12: Nixon IJ, Ganly I, Patel SG, et al. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification. Thyroid. 2013;23(6):683-694. DOI: https://doi.org/10.1089/thy.2012.0307
13: Liu J, Zhang Z, Huang H, et al. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: a single-institution matched-pair analysis. Oral Oncol. 2019;90:17-22. DOI: https://doi.org/10.1016/j.oraloncology.2019.01.010
14: Colombo C, De Leo S, Di Stefano M, et al. Total thyroidectomy vs lobectomy for thyroid cancer: single-center data and literature review. Ann Surg Oncol. 2021;28(8):4334-4344. DOI: https://doi.org/10.1245/s10434-020-09481-8
15: Kwon H, Jeon MJ, Kim WG, et al. A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study. Eur J Endocrinol. 2017;176(4):371-378. DOI: https://doi.org/10.1530/EJE-16-0845
Downloads
Published
Issue
Section
License
Copyright (c) 2024 dr fazliwadud (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
